Michael Holder

Michael Holder serves as the Chief Executive Officer of Sensable Health, a company focused on enhancing individual health through biology, AI, and machine learning. Holder is also a Board Member and Chair of the Audit Committee at Cytek Biosciences, a leading flow cytometry manufacturer. In addition, Holder holds a Board Member position at Keyron Medical Technology, a firm specializing in innovative treatments for metabolic diseases. Previous roles include Chief Financial Officer at AVITA Medical and ImmuneCyte, Inc., and Chief Executive Officer at Longevita BioPharma Partners and Carolina Longevity Institute. Holder's early career includes leadership positions in cyber-security and medical device companies, notably as Chairman and CEO of Organ Transport Systems. Holder earned an MBA in Corporate Strategy and Finance from The Wharton School and a BBA from UNC Kenan-Flagler Business School.